Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Svedbom

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
JAMA Dermatology|April 14, 2021
Long-term Outcomes and Prognosis in New-Onset PsoriasisAxel Svedbom, Lotus Mallbris, Per Larsson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 13, 2021
Costs of patient management over 18 months following a hip, clinical vertebral, distal forearm, or proximal humerus fragility fracture in France-results from the ICUROS studyAstrid Coassy, Axel Svedbom, Hervé Locrelle, et al.
The Journal of Rheumatology|October 1, 2025
GRAPPA 2024 Meeting: Advances in Psoriatic Disease Research From Pilot Grant AwardeesKeith Colaco, Omar Alzayat, Steven Dang, et al.
Bone|December 15, 2020
Health service use pathways associated with recovery of quality of life at 12-months for individual fracture sites: Analyses of the International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS)Jason Talevski, Kerrie M Sanders, Ljoudmila Busija, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 22, 2020
Health Service Use and Quality of Life Recovery 12 Months Following Major Osteoporotic Fracture: Latent Class Analyses of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)Jason Talevski, Kerrie M Sanders, Ljoudmila Busija, et al.
Archives of Osteoporosis|July 15, 2021
Recovery of quality of life is associated with lower mortality 5-year post-fracture: the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS)Jason Talevski, Kerrie M Sanders, Sara Vogrin, et al.
Archives of Osteoporosis|March 4, 2020
Quality of life after fragility fracture in the Russian Federation: results from the Russian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (ICUROS)Olga Lesnyak, Axel Svedbom, Ksenia Belova, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 10, 2022
An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROSAxel Svedbom, Fredrik Borgstöm, Emma Hernlund, et al.
Acta Dermato-Venereologica|April 6, 2023
Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic PharmacotherapyMikael Alsterholm, Axel Svedbom, Chris D Anderson, et al.
The Journal of Investigative Dermatology|May 20, 2025
Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational CohortsAlba Lecumberri, Emilio Berna-Rico, Joel M Gelfand, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
JAMA Dermatology|April 14, 2021
Long-term Outcomes and Prognosis in New-Onset PsoriasisAxel Svedbom, Lotus Mallbris, Per Larsson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 13, 2021
Costs of patient management over 18 months following a hip, clinical vertebral, distal forearm, or proximal humerus fragility fracture in France-results from the ICUROS studyAstrid Coassy, Axel Svedbom, Hervé Locrelle, et al.
The Journal of Rheumatology|October 1, 2025
GRAPPA 2024 Meeting: Advances in Psoriatic Disease Research From Pilot Grant AwardeesKeith Colaco, Omar Alzayat, Steven Dang, et al.
Bone|December 15, 2020
Health service use pathways associated with recovery of quality of life at 12-months for individual fracture sites: Analyses of the International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS)Jason Talevski, Kerrie M Sanders, Ljoudmila Busija, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 22, 2020
Health Service Use and Quality of Life Recovery 12 Months Following Major Osteoporotic Fracture: Latent Class Analyses of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)Jason Talevski, Kerrie M Sanders, Ljoudmila Busija, et al.
Archives of Osteoporosis|July 15, 2021
Recovery of quality of life is associated with lower mortality 5-year post-fracture: the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS)Jason Talevski, Kerrie M Sanders, Sara Vogrin, et al.
Archives of Osteoporosis|March 4, 2020
Quality of life after fragility fracture in the Russian Federation: results from the Russian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (ICUROS)Olga Lesnyak, Axel Svedbom, Ksenia Belova, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 10, 2022
An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROSAxel Svedbom, Fredrik Borgstöm, Emma Hernlund, et al.
Acta Dermato-Venereologica|April 6, 2023
Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic PharmacotherapyMikael Alsterholm, Axel Svedbom, Chris D Anderson, et al.
The Journal of Investigative Dermatology|May 20, 2025
Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational CohortsAlba Lecumberri, Emilio Berna-Rico, Joel M Gelfand, et al.
Pageof 5